Eye Therapies, LLC v. Slayback Pharma LLC
Federal Circuit Affirms Non-Infringement of Glaucoma Treatment Patent
Eye Therapies, LLC v. Slayback Pharma LLC, decided by Federal Circuit on June 30, 2025, resulted in a defendant win outcome. The core dispute centered on whether Slayback Pharma LLC infringed Eye Ther...